Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ladies! Meet Movano: The Fashion-Forward Smart Ring Backed By Medical-Grade Accuracy

Executive Summary

Movano expects to introduce its first smart ring, this one specifically for women, in the first half of 2023 in the US while it continues clinical trials to add medical parameters requiring FDA clearances, such as glucose and blood pressure.

You may also be interested in...



News We’re Watching: Boston Scientific's POLARx Is Approved, IABP Recalls, Intricon Opens Facility in Costa Rica

This week, FDA cleared Terumo's Reveos automated whole blood processing system, Abbott adds the Alinity-h hematology system to its comprehensive lab diagnostics lineup, Movano moves forward with "smart ring" technology, and more.

CES 2023: Beauty Devices And Wellness Tools At ‘Most Influential Tech Event In The World’

The Consumer Technology Association’s 2023 ‘proving ground’ includes Innovation Award-winning devices from Amorepacific to personalize beauty, as well as L’Oreal’s HAPTA, the first handheld, ‘ultra-precise’ computerized makeup applicator for the 50 million people globally who live with limited fine motor skills. More from CES 2023 in Las Vegas.

Period-Tracking Apps Should Safeguard Data, Reassure Customers In Post-Roe Era

Nixon Gwilt Law attorney Bethany Corbin spoke with Medtech Insight about key action steps developers of period-tracking apps can take to ensure that sensitive health data remain safe and private.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145734

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel